Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Caribou Biosciences Inc CRBU

Healthcare Biotechnology
Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its genome-editing platform, including its Cas12a chRDNA technology, enables precision to develop cell therapies that are armored to potentially... see more

Recent & Breaking News (NDAQ:CRBU)

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Caribou Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 20, 2023

Caribou Class Action: Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2023 - CRBU

Newsfile February 20, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - CRBU

Newsfile February 18, 2023

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRBU

Newsfile February 18, 2023

Caribou Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 11, 2023 to Discuss Your Rights - CRBU

Newsfile February 17, 2023

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Caribou Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 17, 2023

Caribou Class Action: Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of April 11, 2023 - CRBU

Newsfile February 16, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Caribou Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 16, 2023

CRBU LAWSUIT ALERT: Levi & Korsinsky Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire February 16, 2023

CARIBOU BIOSCIENCES, INC. (CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. (CRBU)

Newsfile February 15, 2023

Caribou Class Action: Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2023 - CRBU

Newsfile February 15, 2023

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Caribou Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 15, 2023

CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. (NASDAQ: CRBU)

PR Newswire February 15, 2023

CARIBOU ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. and Encourages Investors to Contact the Firm

Business Wire February 14, 2023

CRBU INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU

PR Newswire February 14, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Caribou Biosciences, Inc. (CRBU) Investors of Class Action and to Actively Participate

Business Wire February 14, 2023

Caribou Class Action: Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2023 - CRBU

Newsfile February 14, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Caribou Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 14, 2023

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Caribou Biosciences, Inc. (CRBU)

Business Wire February 13, 2023

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Caribou Biosciences, Inc. (CRBU) Investors - Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Newsfile February 13, 2023